Retrieve available abstracts of 12 articles: HTML format
Single Articles
August 2025
ANKER SD, Karakas M, Mentz RJ, Ponikowski P, et al Systematic review and meta-analysis of intravenous iron therapy for patients with
heart failure and iron deficiency.
Nat Med. 2025;31:2640-2646. PubMedAbstract available
July 2025
AGARWAL R, Bertaina A, Soco C, Long-Boyle JR, et al Irradiation- and busulfan-free stem cell transplantation in Fanconi anemia using
an anti-CD117 antibody: a phase 1b trial.
Nat Med. 2025 Jul 22. doi: 10.1038/s41591-025-03817. PubMedAbstract available
GRIMLEY M, Davies SM, Shrestha A, Shova A, et al Lentiviral gene therapy with reduced-intensity conditioning for sickle cell
disease: a phase 1/2 trial.
Nat Med. 2025;31:2204-2212. PubMedAbstract available
June 2025
LEE S, Son Y, Hwang J, Kim MS, et al Global, regional and national burden of dietary iron deficiency from 1990 to
2021: a Global Burden of Disease study.
Nat Med. 2025;31:1809-1829. PubMedAbstract available
January 2025
PASRICHA SR, Moya E, Ataide R, Mzembe G, et al Author Correction: Ferric carboxymaltose for anemia in late pregnancy: a
randomized controlled trial.
Nat Med. 2025 Jan 13. doi: 10.1038/s41591-025-03492. PubMed
PASRICHA SR, Moya E, Ataide R, Mzembe G, et al Ferric carboxymaltose for anemia in late pregnancy: a randomized controlled
trial.
Nat Med. 2025 Jan 6. doi: 10.1038/s41591-024-03385. PubMedAbstract available
September 2024
BREEYEAR JH, Hellwege JN, Schroeder PH, House JS, et al Adaptive selection at G6PD and disparities in diabetes complications.
Nat Med. 2024;30:2480-2488. PubMedAbstract available
November 2023
SPENCER CHAPMAN M, Cull AH, Ciuculescu MF, Esrick EB, et al Clonal selection of hematopoietic stem cells after gene therapy for sickle cell
disease.
Nat Med. 2023 Nov 16. doi: 10.1038/s41591-023-02636. PubMedAbstract available
CARVALHO T Discontinued CRISPR gene therapy for sickle-cell disease improves symptoms.
Nat Med. 2023;29:2669-2670. PubMed
October 2023
BAHLIS NJ, Costello CL, Raje NS, Levy MY, et al Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1
trial.
Nat Med. 2023;29:2570-2576. PubMedAbstract available
May 2023
ABEDINI A, Klotzer KA, Susztak K Unmasking the elusive erythropoietin-producing 'Norn' cell.
Nat Med. 2023 May 2. doi: 10.1038/s41591-023-02322. PubMed
April 2023
KRAGESTEEN BK, Giladi A, David E, Halevi S, et al The transcriptional and regulatory identity of erythropoietin producing cells.
Nat Med. 2023 Apr 27. doi: 10.1038/s41591-023-02314. PubMedAbstract available